We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-8.45%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$3.03B
AUM Growth
-$263M
Cap. Flow
+$136M
Cap. Flow %
4.51%
Top 10 Hldgs %
30.94%
Holding
140
New
22
Increased
32
Reduced
18
Closed
16

Sector Composition

Rank Sector Weight
1 Healthcare 42.23%
2 Technology 22.61%
3 Industrials 11.22%
4 Consumer Discretionary 8.19%
5 Utilities 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$164M 5.41%
1,698,648
ZGNX
2
DELISTED
Zogenix, Inc.
ZGNX
$114M 3.76%
2,841,300
SAGE
3
DELISTED
Sage Therapeutics
SAGE
$111M 3.66%
790,000
+35,000
+5% +$5.85M
SRPT icon
4
Sarepta Therapeutics
SRPT
$1.64B
$91.8M 3.03%
1,219,000
+96,000
+9% +$11.3M
TWLO icon
5
Twilio
TWLO
$29B
$90.9M 3%
827,000
TTD icon
6
Trade Desk
TTD
$8.59B
$79.7M 2.63%
4,250,000
-560,000
-12% -$13.3M
ROP icon
7
Roper Technologies
ROP
$38.5B
$76.3M 2.52%
214,000
WCN
8
Waste Connections
WCN
$41.9B
$74M 2.44%
804,000
BHVN
9
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$68.2M 2.25%
1,634,000
+811,000
+99% +$34.3M
FIVN icon
10
FIVE9
FIVN
$2.12B
$67.2M 2.22%
1,250,000
+250,000
+25% +$14.1M
AIMT
11
DELISTED
Aimmune Therapeutics
AIMT
$64.6M 2.13%
3,084,000
+309,000
+11% +$6.31M
W icon
12
Wayfair
W
$11.9B
$64.2M 2.12%
573,000
+58,223
+11% +$7.45M
LOW icon
13
Lowe's Companies
LOW
$118B
$64M 2.11%
581,800
XYL icon
14
Xylem
XYL
$27.3B
$62.7M 2.07%
787,100
+104,200
+15% +$8.19M
PANW icon
15
Palo Alto Networks
PANW
$265B
$58.5M 1.93%
1,722,000
XIFR
16
XPLR Infrastructure LP
XIFR
$1.12B
$56.2M 1.86%
1,063,922
+261,722
+33% +$13.2M
HUBS icon
17
HubSpot
HUBS
$11.9B
$53.1M 1.75%
350,000
+33,000
+10% +$5.93M
LRCX icon
18
Lam Research
LRCX
$372B
$52.5M 1.73%
2,270,000
MTD icon
19
Mettler-Toledo International
MTD
$27.9B
$51.1M 1.69%
72,610
+3,710
+5% +$2.72M
SPLK
20
DELISTED
Splunk Inc
SPLK
$50.4M 1.67%
428,000
LII icon
21
Lennox International
LII
$14.5B
$48.6M 1.61%
200,000
+56,000
+39% +$14.4M
VMC icon
22
Vulcan Materials
VMC
$35.2B
$48M 1.59%
317,300
+12,300
+4% +$1.74M
EXAS
23
DELISTED
Exact Sciences
EXAS
$44.7M 1.48%
495,000
ASML icon
24
ASML
ASML
$634B
$44.3M 1.46%
178,400
+5,400
+3% +$1.22M
CCI icon
25
Crown Castle
CCI
$33.4B
$44.3M 1.46%
318,600
-400
-0.1% -$55.3K

Similar funds

Eventide Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Eventide Asset Management held 140 positions worth $3.03B, down 8% from $3.29B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $136M of net new capital in Q3 2019, opening 22 new positions and adding to 32 existing holdings. Its largest new stake was Smartsheet Inc.: 975,000 shares worth $35.1M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was XPO, an estimated $21.4M trimmed.

  • Eventide Asset Management's largest Q3 2019 buy was Smartsheet Inc.: 975,000 shares worth $35.1M.
  • Eventide Asset Management added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $34.3M increase.
  • Eventide Asset Management's biggest Q3 2019 reduction was XPO, cutting an estimated $21.4M.
  • Eventide Asset Management fully exited Talend S.A. American Depositary Shares in Q3 2019, selling an estimated $26.6M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $3.03B portfolio in Q3 2019.
  • Eventide Asset Management opened 22 new positions and closed 16 in Q3 2019.
  • Eventide Asset Management's portfolio value fell 8% quarter-over-quarter to $3.03B.

Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.